Alterations in lymphocyte subsets as prognosticators of postoperative infections. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Alterations in lymphocyte subsets as prognosticators of postoperative infections.

Eur J Surg. 1995 Jul;161(7):493-9. Unique Identifier : AIDSLINE MED/96026958
Gennari R; Dominioni L; Imperatori A; Bianchi V; Maroni P; Dionigi R; Department of Surgery, University of Pavia in Varese, Ospedale; Multizonale, Italy.


Abstract: OBJECTIVE: To evaluate changes in lymphocyte subsets after major abdominal and thoracic operations, and to correlate changes with the development of clinically relevant infections postoperatively. DESIGN: Open study. SETTING: University hospital, Italy. SUBJECTS: 33 patients who were to undergo major abdominal or thoracic operations. INTERVENTIONS: Lymphocyte subsets were measured by cytofluorimetry before operation and 1, 3, 5, and 7 days postoperatively. MAIN OUTCOME MEASURES: Correlation between changes in the number of lymphocyte subsets and development of infection. RESULTS: Lymphocyte subsets were within the reference range in all patients before operation. 10/33 Patients developed infections (pneumonia, bacteraemia, or wound or urinary tract infections) between the second and the ninth days postoperatively (30%). On day 1 the numbers of all lymphocyte subsets had decreased significantly compared with the preoperative measurements in all patients (CD3 p < 0.01, CD4 p < 0.001, and CD8 p < 0.05). The reduction in CD3 was significantly greater in the group that developed infections (p < 0.001). Among patients who did not develop infections the numbers of lymphocyte subsets had returned to the reference range within a week of operation whereas among patients who developed infections they remained depressed (p < 0.05). CONCLUSION: The synchronous reduction in numbers of all lymphocyte subsets on the first day postoperatively to below 50% of the reference range (CD3 to < 600/microliters, CD4 to < 400/microliters, and CD8 to < 250/microliters) predicted the development of infection postoperatively with an accuracy of 89%, a sensitivity of 80%, and a specificity of 96%.
Keywords: Adult Aged CD4 Lymphocyte Count Female Human Infection/ETIOLOGY/*IMMUNOLOGY Lymphocyte Count Male Middle Age Postoperative Complications/ETIOLOGY/*IMMUNOLOGY Prognosis Sensitivity and Specificity Surgical Wound Infection/IMMUNOLOGY T-Lymphocyte Subsets/*IMMUNOLOGY T-Lymphocytes/IMMUNOLOGY T-Lymphocytes, Helper-Inducer/*IMMUNOLOGY T-Lymphocytes, Suppressor-Effector/*IMMUNOLOGY CLINICAL TRIAL JOURNAL ARTICLEKWDadultagedcd4lymphocytecountfemalehumaninfection/etiology/KWDimmunologylymphocytecountmalemiddleagepostoperativecomplications/etiology/KWDimmunologyprognosissensitivityandspecificitysurgicalwoundinfection/immunologyt-lymphocytesubsets/KWDimmunologyt-lymphocytes/immunologyt-lymphocytes,helper-inducer/KWDimmunologyt-lymphocytes,suppressor-effector/KWDimmunologyclinicaltrialjournalarticle
960330
M9630747

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .